UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Experimental neurology, 2003-11, Vol.184 (1), p.285-294

2003

Volltextzugriff (PDF)

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease

The Journal of neuroscience, 2001-05, Vol.21 (10), p.RC143

2001

Volltextzugriff (PDF)

Interactions of Nitrogen-Containing Xenobiotics with Monoamine Oxidase (MAO) Isozymes A and B: SAR Studies on MAO Substrates and Inhibitors

Chemical research in toxicology, 2001-09, Vol.14 (9), p.1139-1162

2001

Volltextzugriff (PDF)

35: Transvaginal sacrospinous sling hysteropexy for the treatment of advanced prolapse: Results of an argentinean experience

American journal of obstetrics and gynecology, 2017-03, Vol.216 (3), p.S594-S595

2017

Volltextzugriff (PDF)

Enhancement of auditory sensory gating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers

Neuroscience letters, 2002-01, Vol.317 (3), p.151-155

2002

Volltextzugriff (PDF)

Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco Leaves

Chemical research in toxicology, 2000-01, Vol.13 (1), p.31-35

2000

Volltextzugriff (PDF)

Inhibition of Monoamine Oxidase Contributes to the Protective Effect of 7‐Nitroindazole Against MPTP Neurotoxicity

Journal of neurochemistry, 1997-10, Vol.69 (4), p.1771-1773

1997

Volltextzugriff (PDF)

Potential Metabolic Bioactivation Pathways Involving Cyclic Tertiary Amines and Azaarenes

Chemical research in toxicology, 1997-09, Vol.10 (9), p.924-940

1997

Volltextzugriff (PDF)

Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco

Chemical research in toxicology, 2001-05, Vol.14 (5), p.523-527

2001

Volltextzugriff (PDF)

The Neuronal Nitric Oxide Synthase Inhibitor 7-Nitroindazole Also Inhibits the Monoamine Oxidase-B-Catalyzed Oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Chemical research in toxicology, 1997-04, Vol.10 (4), p.364-368

1997

Volltextzugriff (PDF)

Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design

Neurology, 2006-10, Vol.67 (7 Suppl 2), p.S5

2006

Volltextzugriff (PDF)

MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies

The Journal of pharmacology and experimental therapeutics, 1994-01, Vol.268 (1), p.380

1994

Volltextzugriff (PDF)

1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies

The Journal of pharmacology and experimental therapeutics, 1994-08, Vol.270 (2), p.822

1994

Volltextzugriff (PDF)

Discovery of a Novel Microsomal Epoxide Hydrolase-Catalyzed Hydration of a Spiro Oxetane

Drug metabolism and disposition, 2016-08, Vol.44 (8), p.1341-1348

2016

Volltextzugriff (PDF)

Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism

Medicinal research reviews, 1995-07, Vol.15 (4), p.325-388

1995

Volltextzugriff (PDF)

tert-Butoxyl as a Model for Radicals in Biological Systems: Caveat Emptor

Journal of the American Chemical Society, 2001-06, Vol.123 (24), p.5808-5809

2001

Volltextzugriff (PDF)

Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives

The Journal of pharmacology and experimental therapeutics, 1999-11, Vol.291 (2), p.856

1999

Volltextzugriff (PDF)

Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors

The Journal of biological chemistry, 2005-04, Vol.280 (16), p.15761-15766

2005

Volltextzugriff (PDF)

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

Biochemical and biophysical research communications, 1990-01, Vol.166 (1), p.238-244

1990

Volltextzugriff (PDF)

Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration

Inflammopharmacology, 2003, Vol.11 (2), p.183-188

2003

Volltextzugriff (PDF)

Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine

Journal of neurochemistry, 1987-07, Vol.49 (1), p.1-8

1987

Volltextzugriff (PDF)

Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite

Chemical research in toxicology, 1991-01, Vol.4 (1), p.123-128

1991

Volltextzugriff (PDF)

Studies on the metabolism of haloperidol (HP): The role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP + found in rat brain following ip administration of HP

Life sciences (1973), 1995-11, Vol.57 (26), p.2439-2446

1995

Volltextzugriff (PDF)

Studies on the in Vivo Biotransformation of the Tobacco Alkaloid β-Nicotyrine

Chemical research in toxicology, 2000-05, Vol.13 (5), p.336-341

2000

Volltextzugriff (PDF)

Assessment of Structural Requirements for the Monoamine Oxidase-B-Catalyzed Oxidation of 1,4-Disubstituted-1,2,3,6-tetrahydropyridine Derivatives Related to the Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Journal of medicinal chemistry, 1996-09, Vol.39 (19), p.3694-3700

1996

Volltextzugriff (PDF)

1 – 25 von 446

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(364)
Mit Volltextzugriff
(331)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease

Interactions of Nitrogen-Containing Xenobiotics with Monoamine Oxidase (MAO) Isozymes A and B: SAR Studies on MAO Substrates and Inhibitors

35: Transvaginal sacrospinous sling hysteropexy for the treatment of advanced prolapse: Results of an argentinean experience

Enhancement of auditory sensory gating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers

Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco Leaves

Inhibition of Monoamine Oxidase Contributes to the Protective Effect of 7‐Nitroindazole Against MPTP Neurotoxicity

Potential Metabolic Bioactivation Pathways Involving Cyclic Tertiary Amines and Azaarenes

Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco

The Neuronal Nitric Oxide Synthase Inhibitor 7-Nitroindazole Also Inhibits the Monoamine Oxidase-B-Catalyzed Oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design

MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies

1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies

Discovery of a Novel Microsomal Epoxide Hydrolase-Catalyzed Hydration of a Spiro Oxetane

Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism

tert-Butoxyl as a Model for Radicals in Biological Systems: Caveat Emptor

Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives

Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration

Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine

Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite

Studies on the metabolism of haloperidol (HP): The role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP + found in rat brain following ip administration of HP

Studies on the in Vivo Biotransformation of the Tobacco Alkaloid β-Nicotyrine

Assessment of Structural Requirements for the Monoamine Oxidase-B-Catalyzed Oxidation of 1,4-Disubstituted-1,2,3,6-tetrahydropyridine Derivatives Related to the Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Suchergebnisse filtern